Recherche
Résultats 1-6 de 6
-
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
American journal of hematology, 2016, 91, 179-184Article dans une revue scientifique -
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Lancet (London, England), 2016, 387, 2402-2411Article dans une revue scientifique -
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group
Haematologica, 2016, 101, 474-481Article dans une revue scientifique -
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Blood, 2016, 127, 411-419Article dans une revue scientifique -
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma
Haematologica, 2016, 101, 226-234Article dans une revue scientifique -
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA
Ann. Oncol., 2016, 27, 1349-1350Article dans une revue scientifique